Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Studies suggest that AOD9604 does not bind the growth hormone receptor and does not activate the JAK2/STAT5 pathway, which accounts for the absence of growth-promoting or IGF-1-elevating effects observed in animal studies
Monitoring and Medical Supervision: While AOD-9604 has a favorable safety profile, medical supervision is recommended, particularly for individuals with pre-existing health conditions
Developed at Monash University in Australia, AOD9604 was designed to isolate the lipolytic activity attributed to the C-terminal region of hGH while excluding the growth-promoting and diabetogenic effects associated with the full-length hormone
Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism
Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health
This classification allows for their use only for research development and laboratory studies
US$ 20.61
US$ 29.93
US$ 21.71
US$ 26.58